Alternative activation of macrophages

Area of Science:

• Immunology
• Cellular Biology

Background:

• The classical pathway of macrophage activation via interferon-gamma (IFN-γ) is crucial for cellular immunity against intracellular pathogens like Mycobacterium tuberculosis and HIV.
• A distinct alternative pathway of macrophage activation has been proposed, mediated by T helper 2 (T(H)2) type cytokines, interleukin-4 (IL-4) and interleukin-13 (IL-13).

Purpose of the Study:

• To review and assess the evidence supporting the concept of alternative macrophage activation.
• To define the characteristics, limitations, and relevance of this alternative pathway in various immune and inflammatory conditions.

Main Methods:

• Literature review and synthesis of existing research on macrophage activation pathways.
• Analysis of macrophage heterogeneity in the context of classical and alternative activation.

Main Results:

• The alternative pathway is associated with a distinct macrophage phenotype.
• This phenotype suggests a role in humoral immunity and tissue repair, differing from the classical pathway's role in infection control.
• Macrophage heterogeneity is a key factor in understanding these distinct activation states.

Conclusions:

• The evidence supports the existence and significance of alternative macrophage activation.
• This pathway has implications for understanding and potentially treating a range of immune and inflammatory diseases.
• Further research is needed to fully elucidate the scope and therapeutic potential of alternative macrophage activation.